Evidence for avoiding the biopsy of typical fibroadenomas in women aged 25–29 years

Taylor, Kathryn M.; Lowes, Simon; Stanley, Emma; Hamilton, P.; Redman, Alan; Leaver, A; Smith, Clare; Lakshman, Rama; Vandersluis, H; Wallis, MG

doi:10.1016/j.crad.2019.02.019

Cited by 6 publications

(8 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The clinical diagnosis of fibroadenoma is mainly based on palpation and imaging examinations, namely ultrasonography, mammography, and magnetic resonance imaging (MRI). The reported that the accuracy of breast ultrasonography in the diagnosis of fibroadenoma is 78.8% to 99.5% [4–9] . The specificity of mammography for diagnosing of fibroadenoma is 83.9%, which is lower than that for ultrasonography (88.2%), [23] but mammography has outstanding advantages for differentiating malignant from benign calcification.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Clinical practice guideline for breast fibroadenoma: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021

Yuan

Xie

Zhao

et al. 2021

Chinese Medical Journal

View full text Add to dashboard Cite

Breast fibroadenoma is the most common benign tumor of the breast in women, and can occur at all ages. However, these tumors are more commonly seen in women aged 15 to 35 years. [1] Most fibroadenomas often undergo selflimited growth and usually stabilize after several years. The clinical diagnosis is mainly based on clinical palpation and ultrasonographic examination, while the golden standard diagnosis is pathological examination. To standardize the clinical diagnosis and treatment of breast fibroadenoma, the Chinese Society of Breast Surgery (CSBrS) conducted a literature review of experts' opinions, and determined the key clinical questions for the clinical practice guideline of breast fibroadenoma. The group evaluated the relevant evidences using the grading of recommendations assessment, development, and evaluation system, and developed the clinical practice guideline for breast fibroadenoma: CSBrS practice guideline 2021, with the aim of providing clinical practice guidance to breast surgeons in China. * For fibroadenomas where VABB is planned, please refer to the Clinical Practice Guidelines for Ultrasound-guided Vacuum-assisted Breast Biopsy for details. BI-RADS: Breast Imaging Reporting and Data System; VABB: Vacuum-assisted breast biopsy.

show abstract

Section: Discussionmentioning

confidence: 99%

“…It is safe not to biopsy of typical fibroadenomas in young women when the clinical and sonographic presentations meet strict criteria. This is because, in these patients, ultrasonography and pathology have good concordance rates, and a missed diagnosis of malignant disease is rare [8,9,18] …”

Section: Discussionmentioning

confidence: 99%

Clinical practice guideline for breast fibroadenoma: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021

Yuan

Xie

Zhao

et al. 2021

Chinese Medical Journal

View full text Add to dashboard Cite

show abstract

“…In K2, U2 (BI-RADS 2–3) cases, patient at normal risk (no multiple positive family history or confirmed gene mutation), with a sharp-edged, ovoid lesion not larger than 3 cm, having homogeneous structure and a longitudinal axis parallel to the skin surface, containing less than four (macro) lobulations, and displaying no hyperechoic halo sign ( 81 – 84 ). • Physical examination • Ultrasound scanning under the age of 30–35 years, complemented by mammography, if needed (suspected malignancy).…”

Section: Assessment Protocolsmentioning

confidence: 99%

Use of Diagnostic Imaging Modalities in Modern Screening, Diagnostics and Management of Breast Tumours 1st Central-Eastern European Professional Consensus Statement on Breast Cancer

Forrai

Kovács²,

Ambrózay³

et al. 2022

Pathol. Oncol. Res.

View full text Add to dashboard Cite

Breast radiologists and nuclear medicine specialists updated their previous recommendation/guidance at the 4th Hungarian Breast Cancer Consensus Conference in Kecskemét. A recommendation is hereby made that breast tumours should be screened, diagnosed and treated according to these guidelines. These professional guidelines include the latest technical developments and research findings, including the role of imaging methods in therapy and follow-up. It includes details on domestic development proposals and also addresses related areas (forensic medicine, media, regulations, reimbursement). The entire material has been agreed with the related medical disciplines.

show abstract

“…Therefore, age has been proposed to guide investigations in the work-up of breast lumps ( Table 2 ). 10 , 13 , 14…”

Section: Age-based Approach To a Palpable Breast Lumpmentioning

confidence: 99%

“…Fibroadenomas are still common in patients between 25 and 30 years of age, but more breast cancers are diagnosed with increasing age. 13 The safest approach would be to remove all palpable breast lumps in patients over 30 years. All lesions that are not excised need to be followed up by regular 6-monthly clinical examination and ultrasound to document stability for a minimum of two years.…”

Section: Age-based Approach To a Palpable Breast Lumpmentioning

confidence: 99%

Palpable breast lumps: An age-based approach to evaluation and diagnosis

et al. 2022

View full text Add to dashboard Cite

A palpable breast lump is a common presentation of breast disease to a general practitioner. Fortunately, investigation of most of these lumps will lead to a benign diagnosis. It is essential to have a clear and systematic approach when investigating a palpable breast lump to avoid over investigation with the resultant increase in healthcare cost and anxiety. This article will discuss an approach to evaluating and diagnosing a palpable breast lump in the primary care setting.

show abstract

Evidence for avoiding the biopsy of typical fibroadenomas in women aged 25–29 years

Cited by 6 publications

References 13 publications

Clinical practice guideline for breast fibroadenoma: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021

Clinical practice guideline for breast fibroadenoma: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021

Use of Diagnostic Imaging Modalities in Modern Screening, Diagnostics and Management of Breast Tumours 1st Central-Eastern European Professional Consensus Statement on Breast Cancer

Palpable breast lumps: An age-based approach to evaluation and diagnosis

Contact Info

Product

Resources

About